生物技術市場規模、份額、趨勢分析:技術(DNA 序列、發酵)、應用(健康、生物資訊學)、地區(北美、歐盟、亞太地區)和分部預測,2022-2030
市場調查報告書
商品編碼
1097090

生物技術市場規模、份額、趨勢分析:技術(DNA 序列、發酵)、應用(健康、生物資訊學)、地區(北美、歐盟、亞太地區)和分部預測,2022-2030

Biotechnology Market Size, Share & Trends Analysis By Technology (DNA Sequencing, Fermentation), By Application (Health, Bioinformatics), By Region (North America, EU, APAC), And Segment Forecasts, 2022 - 2030

出版日期: | 出版商: Grand View Research | 英文 160 Pages | 商品交期: 2-10個工作天內

價格

生物技術市場的增長和趨勢

據正觀研究最新報告顯示,到2030年,全球生物技術市場規模將達到38795.1億美元,預測期內復合年增長率為13.9%,

這一市場的驅動因素包括創新和先進技術的出現、大量投資和政府支持生物技術行業的努力,以及對合成生物學應用不斷增長的需求。生物科技初創企業獲得了強大的資金支持和風險投資,2021年達到410億美元,比上年的367億美元增長11%以上。值得注意的幾輪融資包括 Charis Life Sciences 2021 年 5 月的 8.3 億美元用於擴展精準醫療平台和 Avogen 於 2021 年用於 COVID-19 候選疫苗的臨床開發。Elevate Bio 每月籌集 7 億美元的 C 系列資金和2021 年 3 月的 C 輪融資 5.25 億美元,用於開發細胞和基因治療技術。

此外,2021年新誕生了28家生物科技獨角獸,該領域共有192家獨角獸。政府對生物技術基礎設施的支持也有助於市場增長。例如,印度 2021-22 年聯邦預算包括 2.2794 億美元的生物技術研發儲備金,併計劃在該國建立 9 個生物安全三級實驗室。此外,Illumina Accelerator 等計劃為特定的初創企業提供種子投資、基因組學專業知識以及獲得 Illumina 測序系統和試劑的途徑,以推動市場增長。

COVID-19 大流行正在尋找新的解決方案來開發疫苗和診斷工具來對抗這種疾病。例如,mRNA疫苗的出現得到了生物技術領域尖端技術的支持,例如加快疫苗開發時間的分子研究工具和基因測序方法。此外,2022 年 3 月,針對 COVID-19 的高靈敏度和簡單 PCR 檢測 DASH(特異性雜交診斷分析儀)獲得 FDA 緊急使用批准。該測試已由 Minute Molecular Diagnostics 商業化,可在 15 分鐘內產生結果。分子診斷學的這種進步預計將推動市場增長。

生物技術市場報告亮點

  • 由於高發疾病的流行、對再生醫學的日益關注、COVID-19 流行帶來的技術創新以及醫療保健基礎設施的改善,健康應用領域在 2021 年佔據了最大份額。
  • DNA 測序技術部分在 2021 年佔據第二大份額,原因是測序成本降低和在精準醫療保健開發中的採用率增加。
  • 2021 年,隨著在該地區運營的主要公司推出先進的生物技術解決方案,北美佔據了全球市場的最大份額。
  • 預計 2022 年至 2030 年亞太地區的複合年增長率最快。這是由於印度和中國政府的積極努力以及藥物批准過程中有利的監管變化。

目錄

第 1 章調查方法及範圍

  • 調查地點
  • 調查方法
  • 資訊採購
  • 資訊或數據分析
  • 市場製定與驗證
  • 世界市場:CAGR 計算
  • 目的
    • 目的 1
    • 目的 2
  • 收入建模:COVID-19 之後的市場情景
    • 當前市場動態評價:公司評價
    • 市場動態評估:未來預測
    • 20 強實體:企業利潤和市值分析
      • A部分
      • B部分
      • C部分

第 2 章執行摘要

  • 市場快照

第 3 章市場變量、趨勢和範圍

  • 市場趨勢與展望
  • 市場細分和範圍
  • 市場動態
    • 市場促進因素分析
      • 存在有利的政府舉措
      • 對農產品的需求不斷增加
      • 對合成生物學的需求不斷增加
      • DNA測序價格下跌
      • 增加醫療保健費用以支持開發有效的癌症個體化診斷和治療程序
    • 市場約束分析
      • 道德和法律限制
      • 與轉基因生物和作物相關的風險
      • 與 NGS 實施相關的問題
  • 2021 年技術滲透率和增長前景圖
  • 2021 年市場份額分析
  • 商業環境分析
    • SWOT 分析;按因素(政治和法律、經濟和技術)
    • 波特五力分析

第 4 章生物技術分類:應用評估/趨勢分析

  • 生物技術市場:應用波動分析
  • 健康
    • COVID 之前的細分場景
    • COVID 之後的細分場景
    • 2018-2030 年全球健康生物技術市場(10 億美元)
  • 糧食及農業組織
    • COVID 之前的細分場景
    • COVID 之後的細分場景
    • 2018-2030 年全球食品和農業生物技術市場(10 億美元)
  • 自然資源與環境
    • COVID 之前的細分場景
    • COVID 之後的細分場景
    • 2018-2030 年全球自然資源與環境生物技術市場(10 億美元)
  • 工業加工
    • COVID 之前的細分場景
    • COVID 之後的細分場景
    • 2018-2030 年全球工業加工生物技術市場(10 億美元)
  • 生物資訊學
    • COVID 之前的細分場景
    • COVID 之後的細分場景
    • 2018-2030年全球生物信息學生物技術市場(10億美元)
  • 其他應用
    • 2018-2030 年全球生物技術應用市場(10 億美元)

第 5 章生物技術市場分類:技術估計/趨勢分析

  • 生物技術市場:技術波動分析
  • DNA測序
    • COVID 之前的細分場景
    • COVID 之後的細分場景
    • 2018-2030 年全球 DNA 測序生物技術市場(10 億美元)
  • 納米生物技術
    • COVID 之前的細分場景
    • COVID 之後的細分場景
    • 2018-2030 年全球納米生物技術生物技術市場(10 億美元)
  • 組織工程與再生
    • COVID 之前的細分場景
    • COVID 之後的細分場景
    • 2018-2030 年全球組織工程和再生生物技術市場(10 億美元)
  • 發酵
    • COVID 之前的細分場景
    • COVID 之後的細分場景
    • 生物製藥製造
    • 生物製藥和生物技術調查
    • 其他
    • 2018-2030 年全球發酵生物技術市場(10 億美元)
  • 基於細胞的檢測
    • COVID 之前的細分場景
    • COVID 之後的細分場景
    • 2018-2030 年全球細胞檢測生物技術市場(10 億美元)
  • PCR技術
    • COVID 之前的細分場景
    • COVID 之後的細分場景
    • 2018-2030 年全球 PCR 技術生物技術市場(10 億美元)
  • 色譜法
    • COVID 之前的細分場景
    • COVID 之後的細分場景
    • 2018-2030 年色譜全球生物技術市場(10 億美元)
  • 其他技術
    • COVID 之前的細分場景
    • COVID 之後的細分場景
    • 2018-2030 年其他技術的全球生物技術市場(10 億美元)

第 6 章生物技術市場分類:區域估計/趨勢分析,按應用和技術

  • 2021 年和 2030 年區域生物技術份額
  • 北美
    • 美國
    • 加拿大
  • 歐洲
      • 德國
    • 英國
    • 法國
    • 義大利
    • 西班牙
  • 亞太地區
    • 日本
    • 中國
    • 印度
    • 韓國
    • 澳大利亞
  • 拉丁美洲
    • 巴西
    • 墨西哥
  • 中東和非洲 (MEA)
    • 南非
    • 沙特阿拉伯

第 7 章競爭態勢

  • 戰略框架
  • 公司簡介
    • AstraZeneca
      • 公司簡介
      • 財務表現
      • 產品基準
      • 戰略舉措
    • Gilead Sciences Inc.
      • 公司簡介
      • 財務表現
      • 產品基準
      • 戰略舉措
    • Bristol-Myers Squibb
      • 公司簡介
      • 新基公司
      • 財務表現
      • 產品基準
      • 戰略舉措
    • Biogen
      • 公司簡介
      • 財務表現
      • 產品基準
      • 戰略舉措
    • Abbott Laboratories
      • 公司簡介
      • 財務表現
      • 產品基準
      • 戰略舉措
    • Amgen Inc.
      • 公司簡介
      • 財務表現
      • 產品基準
      • 戰略舉措
    • Novo Nordisk A/S
      • 公司簡介
      • 財務表現
      • 產品基準
      • 戰略舉措
    • Merck KGaA
      • 公司簡介
      • 財務表現
      • 產品基準
      • 戰略舉措
    • Johnson & Johnson Services
      • 公司簡介
      • 財務表現
      • 產品基準
      • 戰略舉措
    • Novartis AG
      • 公司簡介
      • 財務表現
      • 產品基準
      • 戰略舉措
    • Sanofi
      • 公司簡介
      • 健□
      • 財務表現
      • 產品基準
      • 戰略舉措
    • F. Hoffman-La Roche Co., Ltd.
      • 公司簡介
      • 財務表現
      • 產品基準
      • 戰略舉措
    • Pfizer Inc.
      • 公司簡介
      • 財務表現
      • 產品基準
      • 戰略舉措
    • Lonza
      • 公司簡介
      • 財務表現
      • 產品基準
      • 戰略舉措
Product Code: 978-1-68038-134-4

Biotechnology Market Growth & Trends:

The global biotechnology market size is expected to reach USD 3,879.51 billion by 2030, registering a CAGR of 13.9% over the forecast period, according to a new report by Grand View Research, Inc. The market is driven by factors including the advent of innovative and advanced technologies, significant investments & government initiatives favoring the biotechnology industry, and rising demand for synthetic biology applications. Biotechnology startups are acquiring robust funding support and venture capital investments, which, in 2021, amounted to USD 41 billion; an increase of over 11% as compared to the previous year's USD 36.7 billion. Notable funding rounds included Caris Life Sciences' $830 million in May 2021 for its precision medicine platform expansion, Abogen's $700 million Series C funding in August 2021 for its COVID-19 vaccine candidate's clinical development, & ElevateBio's $525 million Series C funding in March 2021 for advancing its cell & gene therapy technologies.

In addition, 28 new biotech unicorns were created in 2021, leading to a total of 192 unicorns present in the sector. Government support for the development of biotechnological infrastructure is also contributing to market growth. For instance, India's Union Budget 2021-22 consisted of a provision of USD 227.94 million for biotechnology R&D, along with plans for the setting up of nine biosafety level-3 laboratories in the country. Furthermore, initiatives, such as Illumina Accelerator, are providing access to seed investment, genomics expertise, and Illumina sequencing systems & reagents to selected emerging companies and propelling the market growth.

Due to the COVID-19 pandemic, novel solutions are being explored in the development of vaccines & diagnostic tools for combating the disease. For instance, the advent of mRNA vaccines was supported by cutting-edge technologies in the biotechnology sector, including molecular research tools & genetic sequencing methods that accelerated the timelines for vaccine development. Furthermore, in March 2022, the Diagnostic Analyzer for Specific Hybridization (DASH), a highly sensitive and easy-to-perform PCR test for COVID-19, received FDA emergency use authorization. The test is commercialized by Minute Molecular Diagnostics and can deliver results within 15 minutes. Such advancements in molecular diagnostics are expected to fuel market growth.

Biotechnology Market Report Highlights:

  • The health application segment accounted for the largest share in 2021 due to high disease prevalence, increasing focus on regenerative medicines, innovations in technologies fueled by the COVID-19 pandemic, and improvements in healthcare infrastructure
  • The DNA sequencing technology segment accounted for the second-largest share in 2021 as a result of declining costs of sequencing and its increasing adoption in precision medicine development
  • North America held the largest share of the global market in 2021 owing to the launch of advanced biotechnological solutions facilitated by key players operating in the region
  • Asia Pacific is expected to register the fastest CAGR from 2022 to 2030 due to promising government initiatives and favorable regulatory changes in drug approval processes in India and China

Table of Contents

Chapter 1 Methodology and Scope

  • 1.1 Research Assumptions
  • 1.2 Research Methodology
  • 1.3 Information Procurement
  • 1.4 Information or Data Analysis
  • 1.5 Market Formulation and Validation
  • 1.6 Global Market: CAGR Calculation
  • 1.7 Objectives
    • 1.7.1 Objective 1
    • 1.7.2 Objective 2
  • 1.8 Revenue Modeling: Post-COVID-19 Market Scenario
    • 1.8.1 Present market dynamics assessment: Company evaluation
    • 1.8.2 Market dynamics assessment: future projections
    • 1.8.3 Top 20 operational entities: Company revenue & market value analysis
      • 1.8.3.1 Part A
      • 1.8.3.2 Part B
      • 1.8.3.3 Part C

Chapter 2 Executive Summary

  • 2.1 Market Snapshot

Chapter 3 Market Variables, Trends, and Scope

  • 3.1 Market Trends and Outlook
  • 3.2 Market Segmentation and Scope
  • 3.3 Market Dynamics
    • 3.3.1 Market driver analysis
      • 3.3.1.1 Presence of favorable government initiatives
      • 3.3.1.2 Rising demand for agro-based products
      • 3.3.1.3 Growing demand for synthetic biology
      • 3.3.1.4 Declining prices of DNA sequencing
      • 3.3.1.5 Growing healthcare expenditure boosting development of effective personalized diagnostic & therapeutic procedures for cancer
    • 3.3.2 Market restraint analysis
      • 3.3.2.1 Ethical & legal limitations
      • 3.3.2.2 Risks associated with GM organisms and crops
      • 3.3.2.3 Challenges associated with NGS implementation
  • 3.4 Penetration and Growth Prospect Mapping for Technology, 2021
  • 3.5 Market Share Analysis, 2021
  • 3.6 Business Environment Analysis
    • 3.6.1 SWOT Analysis; By factor (Political & Legal, Economic and Technological)
    • 3.6.2 Porter's Five Forces Analysis

Chapter 4 Biotechnology Categorization: Application Estimates & Trend Analysis

  • 4.1 Biotechnology Market: Application Movement Analysis
  • 4.2 Health
    • 4.2.1 Pre-COVID Segment Scenario
    • 4.2.2 Post-COVID Segment Scenario
    • 4.2.3 Global health Biotechnology market, 2018 - 2030 (USD Billion)
  • 4.3 Food & Agriculture
    • 4.3.1 Pre-COVID Segment Scenario
    • 4.3.2 Post-COVID Segment Scenario
    • 4.3.3 Global Food & Agriculture Biotechnology market, 2018 - 2030 (USD Billion)
  • 4.4 Natural Resources & Environment
    • 4.4.1 Pre-COVID Segment Scenario
    • 4.4.2 Post-COVID Segment Scenario
    • 4.4.3 Global Natural resources & environment Biotechnology market, 2018 - 2030 (USD Billion)
  • 4.5 Industrial Processing
    • 4.5.1 Pre-COVID Segment Scenario
    • 4.5.2 Post-COVID Segment Scenario
    • 4.5.3 Global Industrial processing Biotechnology market, 2018 - 2030 (USD Billion)
  • 4.6 Bioinformatics
    • 4.6.1 Pre-COVID Segment Scenario
    • 4.6.2 Post-COVID Segment Scenario
    • 4.6.3 Global Bioinformatics Biotechnology market, 2018 - 2030 (USD Billion)
  • 4.7 Other Applications
    • 4.7.1 Global Biotechnology market for applications, 2018 - 2030 (USD Billion)

Chapter 5 Biotechnology Market Categorization: Technology Estimates & Trend Analysis

  • 5.1 Biotechnology Market: Technology Movement Analysis
  • 5.2 DNA Sequencing
    • 5.2.1 Pre-COVID Segment Scenario
    • 5.2.2 Post-COVID Segment Scenario
    • 5.2.3 Global Biotechnology market for DNA Sequencing, 2018 - 2030 (USD Billion)
  • 5.3 Nanobiotechnology
    • 5.3.1 Pre-COVID Segment Scenario
    • 5.3.2 Post-COVID Segment Scenario
    • 5.3.3 Global Biotechnology market for Nanobiotechnology, 2018 - 2030 (USD Billion)
  • 5.4 Tissue Engineering & Regeneration
    • 5.4.1 Pre-COVID Segment Scenario
    • 5.4.2 Post-COVID Segment Scenario
    • 5.4.3 Global Biotechnology market for Tissue engineering and regeneration, 2018 - 2030 (USD Billion)
  • 5.5 Fermentation
    • 5.5.1 Pre-COVID Segment Scenario
    • 5.5.2 Post-COVID Segment Scenario
    • 5.5.3 Biopharmaceutical Manufacturing
    • 5.5.4 Biopharmaceutical & Biotechnology Research
    • 5.5.5 Others
    • 5.5.6 Global Biotechnology market for Fermentation, 2018 - 2030 (USD Billion)
  • 5.6 Cell-based Assays
    • 5.6.1 Pre-COVID Segment Scenario
    • 5.6.2 Post-COVID Segment Scenario
    • 5.6.3 Global Biotechnology market for Cell-based assays, 2018 - 2030 (USD Billion)
  • 5.7 PCR Technology
    • 5.7.1 Pre-COVID Segment Scenario
    • 5.7.2 Post-COVID Segment Scenario
    • 5.7.3 Global Biotechnology market for PCR technology, 2018 - 2030 (USD Billion)
  • 5.8 Chromatography
    • 5.8.1 Pre-COVID Segment Scenario
    • 5.8.2 Post-COVID Segment Scenario
    • 5.8.3 Global Biotechnology market for Chromatography, 2018 - 2030 (USD Billion)
  • 5.9 Other Technologies
    • 5.9.1 Pre-COVID Segment Scenario
    • 5.9.2 Post-COVID Segment Scenario
    • 5.9.3 Global Biotechnology market for Other technologies, 2018 - 2030 (USD Billion)

Chapter 6 Biotechnology Market Categorization: Regional Estimates & Trend Analysis, by Application & Technology

  • 6.1 Biotechnology Share by Regional, 2021 & 2030
  • 6.2 North America
    • 6.2.1 U.S.
    • 6.2.2 Canada
  • 6.3 Europe
      • 6.3.1Germany
    • 6.3.2 U.K.
    • 6.3.3 France
    • 6.3.4 Italy
    • 6.3.5 Spain
  • 6.4 Asia-Pacific
    • 6.4.1 Japan
    • 6.4.2 China
    • 6.4.3 India
    • 6.4.4 South Korea
    • 6.4.5 Australia
  • 6.5 Latin America
    • 6.5.1 Brazil
    • 6.5.2 Mexico
  • 6.6 Middle East and Africa (MEA)
    • 6.6.1 South Africa
    • 6.6.2 Saudi Arabia

Chapter 7 Competitive Landscape

  • 7.1 Strategy Framework
  • 7.2 Company Profiles
    • 7.2.1 AstraZeneca
      • 7.2.1.1 Company Overview
      • 7.2.1.2 Financial Performance
      • 7.2.1.3 Product Benchmarking
      • 7.2.1.4 Strategic Initiatives
    • 7.2.2 Gilead Sciences Inc.
      • 7.2.2.1 Company Overview
      • 7.2.2.2 Financial Performance
      • 7.2.2.3 Product Benchmarking
      • 7.2.2.4 Strategic Initiatives
    • 7.2.3 Bristol-Myers Squibb
      • 7.2.3.1 Company Overview
      • 7.2.3.1.1 Celgene Corporation
      • 7.2.3.2 Financial Performance
      • 7.2.3.3 Product Benchmarking
      • 7.2.3.4 Strategic Initiatives
    • 7.2.4 Biogen
      • 7.2.4.1 Company Overview
      • 7.2.4.2 Financial Performance
      • 7.2.4.3 Product Benchmarking
      • 7.2.4.4 Strategic Initiatives
    • 7.2.5 Abbott Laboratories
      • 7.2.5.1 Company Overview
      • 7.2.5.2 Financial Performance
      • 7.2.5.3 Product Benchmarking
      • 7.2.5.4 Strategic Initiatives
    • 7.2.6 Amgen Inc.
      • 7.2.6.1 Company Overview
      • 7.2.6.2 Financial Performance
      • 7.2.6.3 Product Benchmarking
      • 7.2.6.4 Strategic Initiatives
    • 7.2.7 Novo Nordisk A/S
      • 7.2.7.1 Company Overview
      • 7.2.7.2 Financial Performance
      • 7.2.7.3 Product Benchmarking
      • 7.2.7.4 Strategic Initiatives
    • 7.2.8 Merck KGaA
      • 7.2.8.1 Company Overview
      • 7.2.8.2 Financial Performance
      • 7.2.8.3 Product Benchmarking
      • 7.2.8.4 Strategic Initiatives
    • 7.2.9 Johnson & Johnson Services
      • 7.2.9.1 Company Overview
      • 7.2.9.2 Financial Performance
      • 7.2.9.3 Product Benchmarking
      • 7.2.9.4 Strategic Initiatives
    • 7.2.10 Novartis AG
      • 7.2.10.1 Company Overview
      • 7.2.10.2 Financial Performance
      • 7.2.10.3 Product Benchmarking
      • 7.2.10.4 Strategic Initiatives
    • 7.2.11 Sanofi
      • 7.2.11.1 Company overview
      • 7.2.11.1.1 Genzyme
      • 7.2.11.2 Financial Performance
      • 7.2.11.3 Product Benchmarking
      • 7.2.11.4 Strategic Initiatives
    • 7.2.12 F. Hoffmann-La Roche Ltd.
      • 7.2.12.1 Company Overview
      • 7.2.12.2 Financial Performance
      • 7.2.12.3 Product Benchmarking
      • 7.2.12.4 Strategic Initiatives
    • 7.2.13 Pfizer Inc.
      • 7.2.13.1 Company overview
      • 7.2.13.2 Financial Performance
      • 7.2.13.3 Product Benchmarking
      • 7.2.13.4 Strategic Initiatives
    • 7.2.14 Lonza
      • 7.2.14.1 Company Overview
      • 7.2.14.2 Financial Performance
      • 7.2.14.3 Product Benchmarking
      • 7.2.14.4 Strategic Initiatives

List of Tables

  • Table 1 Healthcare expenditure levels, 2018 - 2022
  • Table 2 Various approaches in regenerative medicine for dermatological use
  • Table 3 North America: Clinical studies using HCT for hematopoietic and non-hematopoietic conditions
  • Table 4 North America biotechnology market estimates & forecasts, by application, 2018 - 2030 (USD Billion)
  • Table 5 North America biotechnology market estimates & forecasts, by technology, 2018 - 2030 (USD Billion)
  • Table 6 U.S. biotechnology market estimates & forecasts, by application, 2018 - 2030 (USD Billion)
  • Table 7 U.S. biotechnology market estimates & forecasts, by technology, 2018 - 2030 (USD Billion)
  • Table 8 Canada biotechnology market estimates & forecasts, by application, 2018 - 2030 (USD Billion)
  • Table 9 Canada biotechnology market estimates & forecasts, by technology, 2018 - 2030 (USD Billion)
  • Table 10 Europe biotechnology market estimates & forecasts, by application, 2018 - 2030 (USD Billion)
  • Table 11 Europe biotechnology market estimates & forecasts, by technology, 2018 - 2030 (USD Billion)
  • Table 12 Germany biotechnology market estimates & forecasts, by application, 2018 - 2030 (USD Billion)
  • Table 13 Germany biotechnology market estimates & forecasts, by technology, 2018 - 2030 (USD Billion)
  • Table 14 U.K. biotechnology market estimates & forecasts, by application, 2018 - 2030 (USD Billion)
  • Table 15 U.K. biotechnology market estimates & forecasts, by technology, 2018 - 2030 (USD Billion)
  • Table 16 France biotechnology market estimates & forecasts, by application, 2018 - 2030 (USD Billion)
  • Table 17 France biotechnology market estimates & forecasts, by technology, 2018 - 2030 (USD Billion)
  • Table 18 Italy biotechnology market estimates & forecasts, by application, 2018 - 2030 (USD Billion)
  • Table 19 Italy biotechnology market estimates & forecasts, by technology, 2018 - 2030 (USD Billion)
  • Table 20 Spain biotechnology market estimates & forecasts, by application, 2018 - 2030 (USD Billion)
  • Table 21 Spain biotechnology market estimates & forecasts, by technology, 2018 - 2030 (USD Billion)
  • Table 22 Asia Pacific biotechnology market estimates & forecasts, by application, 2018 - 2030 (USD Billion)
  • Table 23 Asia Pacific biotechnology market estimates & forecasts, by technology, 2018 - 2030 (USD Billion)
  • Table 24 Japan biotechnology market estimates & forecasts, by application, 2018 - 2030 (USD Billion)
  • Table 25 Japan biotechnology market estimates & forecasts, by technology, 2018 - 2030 (USD Billion)
  • Table 26 Main monographs published in China
  • Table 27 China biotechnology market estimates & forecasts, by application, 2018 - 2030 (USD Billion)
  • Table 28 China biotechnology market estimates & forecasts, by technology, 2018 - 2030 (USD Billion)
  • Table 29 India biotechnology market estimates & forecasts, by application, 2018 - 2030 (USD Billion)
  • Table 30 India biotechnology market estimates & forecasts, by technology, 2018 - 2030 (USD Billion)
  • Table 31 South Korea biotechnology market estimates & forecasts, by application, 2018 - 2030 (USD Billion)
  • Table 32 South Korea biotechnology market estimates & forecasts, by technology, 2018 - 2030 (USD Billion)
  • Table 33 Australia biotechnology market estimates & forecasts, by application, 2018 - 2030 (USD Billion)
  • Table 34 Australia biotechnology market estimates & forecasts, by technology, 2018 - 2030 (USD Billion)
  • Table 35 Latin America: Current initiatives and opportunities
  • Table 36 Latin America biotechnology market estimates & forecasts, by application, 2018 - 2030 (USD Billion)
  • Table 37 Latin America biotechnology market estimates & forecasts, by technology, 2018 - 2030 (USD Billion)
  • Table 38 Brazil biotechnology market estimates & forecasts, by application, 2018 - 2030 (USD Billion)
  • Table 39 Brazil biotechnology market estimates & forecasts, by technology, 2018 - 2030 (USD Billion)
  • Table 40 Mexico biotechnology market estimates & forecasts, by application, 2018 - 2030 (USD Billion)
  • Table 41 Mexico biotechnology market estimates & forecasts, by technology, 2018 - 2030 (USD Billion)
  • Table 42 MEA biotechnology market estimates & forecasts, by application, 2018 - 2030 (USD Billion)
  • Table 43 MEA biotechnology market estimates & forecasts, by technology, 2018 - 2030 (USD Billion)
  • Table 44 South Africa biotechnology market estimates & forecasts, by application, 2018 - 2030 (USD Billion)
  • Table 45 South Africa biotechnology market estimates & forecasts, by technology, 2018 - 2030 (USD Billion)
  • Table 46 Saudi Arabia biotechnology market estimates & forecasts, by application, 2018 - 2030 (USD Billion)
  • Table 47 Saudi Arabia biotechnology market estimates & forecasts, by technology, 2018 - 2030 (USD Billion) 
  • Table 48List of companies evaluated for revenue modeling: Post-COVID market scenario
  • Table 49 Top 10 companies: Market value analysis, 2021 Vs 2022 (As of January) in USD billion
  • Table 50 NIH common fund awards for biomedical research
  • Table 51 Business grants for life science and biotech in Canada
  • Table 52 Applications of bioinformatics tools
  • Table 53 Types of cell-based assays and methods of quantification

List of Figures

  • Fig. 1 Market research process
  • Fig. 2 Information procurement
  • Fig. 3 Primary research
  • Fig. 4 Market research approaches
  • Fig. 5 Value chain-based sizing & forecasting
  • Fig. 6 QFD modeling for market share assessment
  • Fig. 7 Market formulation & validation
  • Fig. 8 Top 10 companies: Market revenue analysis, 2021 (USD Billion)
  • Fig. 9 Top 10 companies: Market capital analysis, 2021 (USD Billion)
  • Fig. 10 Top 10 companies: Market value analysis, 2021 Vs 2022 (As of January) in USD billion
  • Fig. 11 Market summary, 2021 (USD Billion)
  • Fig. 12 Market trends & outlook
  • Fig. 13 Market segmentation and scope
  • Fig. 14 Market driver relevance analysis (Current & future impact)
  • Fig. 15 Global financings for regenerative medicine, 2018
  • Fig. 16 DNA sequencing: Cost per MB, 2010 - August 2020
  • Fig. 17 Cost of per human genome, 2010 - August 2020
  • Fig. 18 Market restraint relevance analysis (Current & future impact)
  • Fig. 19 Side effects of GM foods
  • Fig. 20 Bottlenecks associated with implementation of NGS
  • Fig. 21 Penetration and growth prospect mapping for technology, 2021
  • Fig. 22 Company market share analysis, 2021
  • Fig. 23 SWOT Analysis, By Factor (Political & legal Economic and technological)
  • Fig. 24 Porter's Five Forces Analysis
  • Fig. 25 Biotechnology market: Application outlook key takeaways
  • Fig. 26 Biotechnology market: Application movement analysis
  • Fig. 27 Advantages of biotechnology
  • Fig. 28 Gene therapy clinical trials number as of February 10, 2021
  • Fig. 29 Global health biotechnology market, 2018 - 2030 (USD Billion)
  • Fig. 30 Adoption of GM crops by region (millions of hectares)
  • Fig. 31 Trait enhancement in plants & crops through recombinant DNA technology
  • Fig. 32 Global food & agriculture biotechnology market, 2018 - 2030 (USD Billion)
  • Fig. 33 Global natural resources & environment biotechnology market, 2018 - 2030 (USD Billion)
  • Fig. 34 Global industrial processing biotechnology market, 2018 - 2030 (USD Billion)
  • Fig. 35 Global bioinformatics biotechnology market, 2018 - 2030 (USD Billion)
  • Fig. 36 Global biotechnology market for other applications, 2018 - 2030 (USD Billion)
  • Fig. 37 Biotechnology market: Technology outlook key takeaways
  • Fig. 38 Biotechnology market: Technology movement analysis
  • Fig. 39 Matrix of classification of the first, second, and third generation sequencing based on sequencing chemistry
  • Fig. 40 Global biotechnology market for DNA sequencing, 2018 - 2030 (USD Billion)
  • Fig. 41 Breakdown of nanomedicine products in phase III by therapeutic areas
  • Fig. 42 Types of therapeutic nanoparticles
  • Fig. 43 Global biotechnology market for nanobiotechnology, 2018 - 2030 (USD Billion)
  • Fig. 44 Global biotechnology market for tissue engineering and regeneration, 2018 - 2030 (USD Billion)
  • Fig. 45 Benefits of fermented food
  • Fig. 46 Global biotechnology market for fermentation, 2018 - 2030 (USD Billion)
  • Fig. 47 Global biotechnology market for cell-based assays, 2018 - 2030 (USD Billion)
  • Fig. 48 Global biotechnology market for PCR technology, 2018 - 2030 (USD Billion)
  • Fig. 49 Global biotechnology market for chromatography, 2018 - 2030 (USD Billion)
  • Fig. 50 Global biotechnology market for other technologies, 2018 - 2030 (USD Billion)
  • Fig. 51 Regional marketplace: Key takeaway
  • Fig. 52 Biotechnology regional outlook, 2021 & 2030
  • Fig. 53 North America biotechnology market, 2018 - 2030 (USD Billion)
  • Fig. 54 U.S. biotechnology market, 2018 - 2030 (USD Billion)
  • Fig. 55 Canada biotechnology market, 2018 - 2030 (USD Billion)
  • Fig. 56 Europe biotechnology market, 2018 - 2030 (USD Billion)
  • Fig. 57 Germany biotechnology market, 2018 - 2030 (USD Billion)
  • Fig. 58 U.K. biotechnology market, 2018 - 2030 (USD Billion)
  • Fig. 59 France biotechnology market, 2018 - 2030 (USD Billion)
  • Fig. 60 Italy biotechnology market, 2018 - 2030 (USD Billion)
  • Fig. 61 Spain biotechnology market, 2018 - 2030 (USD Billion)
  • Fig. 62 Asia-Pacific biotechnology market, 2018 - 2030 (USD Billion)
  • Fig. 63 Japan biotechnology market, 2018 - 2030 (USD Billion)
  • Fig. 64 China biotechnology market, 2018 - 2030 (USD Billion)
  • Fig. 65 India biotechnology market, 2018 - 2030 (USD Billion)
  • Fig. 66 South Korea biotechnology market, 2018 - 2030 (USD Billion)
  • Fig. 67 Australia biotechnology market, 2018 - 2030 (USD Billion)
  • Fig. 68 Latin America biotechnology market, 2018 - 2030 (USD Billion)
  • Fig. 69 Brazil biotechnology market, 2018 - 2030 (USD Billion)
  • Fig. 70 Mexico biotechnology market, 2018 - 2030 (USD Billion)
  • Fig. 71 Middle East & Africa (MEA) biotechnology market, 2018 - 2030 (USD Billion)
  • Fig. 72 South Africa biotechnology market, 2018 - 2030 (USD Billion)
  • Fig. 73 Saudi Arabia biotechnology market, 2018 - 2030 (USD Billion)
  • Fig. 74 Strategy framework
  • Fig. 75 Participant categorization